Biosimilars and Biologics Market Driven by aging populations and patent cliffs, the biosimilars & biologics market will grow from ~$531B in ...

Initially, Dr Reddy's will focus on launching the generic semaglutide in Canada, India, Brazil, Turkey, and other emerging ...

Dr. Reddy's Laboratories intends to introduce a more affordable generic version of Novo Nordisk's popular weight-loss ...

India’s Dr Reddy’s Laboratories Ltd. is gearing up to launch a generic version of semaglutide — the active ingredient in Novo ...

Dr Reddy's Laboratories plans to launch a cheaper copycat version of Novo Nordisk's blockbuster weight-loss drug Wegovy in 87 ...

Viatris offers value with high free cash flow and dividends but faces growth challenges from legacy drug price erosion and ...

With over three decades of experience across India, ASEAN, and Australia, Deepali Naair brings deep expertise in brand ...

Biocon Biologics appoints Deepali Naair as Global Head of Brand & Corporate Communications. She brings 30+ years experience ...

On Wednesday, 2005 stocks advanced, 2025 declined and 168 remained unchanged on Bombay Stock Exchange with advance decline ...

Naair will lead Biocon Biologics' global brand and corporate communications strategy as part of its executive team, reporting ...

This article highlights the top B.Tech Biotechnology colleges in India for 2025, detailing their course durations, fees, and ...